Inaktiver Wert

Kurs Onyx Pharmaceuticals, Inc.

Aktien

Schlusskurs Nasdaq
- ^USD	-

01.10.15	Onyx Pharmaceuticals : Amgen Receives CHMP Positive Opinions for Two New Treatment Options for Patients with Blood Cancer in Europe
23.07.15	Onyx Pharmaceuticals : Amgen Submits Supplemental New Drug Application for Kyprolis® (Carflizomib) in Relapsed Multiple Myeloma
31.05.15	Onyx Pharmaceuticals : Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (Carflizomib) in Patients with Relapsed and Refractory Multiple Myeloma
27.05.15	Onyx Pharmaceuticals : Amgen to Advance Understanding of the Treatment of Blood Cancers at the 20th Congress of European Hematology Association (EHA)
13.05.15	Onyx Pharmaceuticals : Amgen Data at ASCO 2015 Highlight Oncology Pipeline and Portfolio

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	% 1 Jahr	Veränd. 3 Jahre	Kap.($)
WUXI APPTEC CO., LTD.	-1.59%	-3.35%	+64.49%	+98.69%	70.64 Mrd.
ARGENX SE	-1.34%	-0.75%	+48.56%	+90.63%	66.11 Mrd.
BIONTECH SE	-8.37%	-12.43%	+0.14%	-15.42%	27.98 Mrd.
INSMED INCORPORATED	-2.35%	-5.75%	-12.17%	+448.29%	26.51 Mrd.
WUXI BIOLOGICS (CAYMAN) INC.	+0.30%	-0.69%	+63.18%	+11.93%	26.44 Mrd.
PHARMAESSENTIA CORPORATION	-0.96%	+10.36%	+278.86%	+438.78%	20.4 Mrd.
GENMAB A/S	-0.51%	+0.23%	+33.71%	-18.02%	20.17 Mrd.
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.91%	-4.37%	+13.33%	+531.29%	15.99 Mrd.
EXELIXIS, INC.	-1.47%	+0.68%	+43.67%	+145.49%	13.69 Mrd.
Durchschnitt	-2.02%	+0.19%	+59.31%	+192.41%	31.99 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung	-1.98%	+0.11%	+56.60%	+152.15%

Beschäftigte

Sektor